News

Filter

Current filters:

None

201 to 210 of 96134 results

NHS England boosts the Cancer Drugs Fund for more access to innovative medicines

NHS England boosts the Cancer Drugs Fund for more access to innovative medicines

28-08-2014

The National Health Service England has pledged to boost the Cancer Drugs Fund by £160 million ($265…

Cancer Drugs FundNHS EnglandOncologyPharmaceuticalRegulationUK

Analysis of Roche’s InterMune acquisition

Analysis of Roche’s InterMune acquisition

28-08-2014

The acquisition of InterMune gives Swiss drug major Roche a substantial opportunity, owing to the Breakthrough…

BiotechnologyIdiopathic pulmonary fibrosisInterMuneMergers & AcquisitionspirfenidonePulmozymeRespiratory and PulmonaryRocheSwitzerlandXolair

BTG and SciClone's DC Bead liver cancer therapy approved in China

BTG and SciClone's DC Bead liver cancer therapy approved in China

28-08-2014

UK specialist health care company BTG and its partner, China-focused US specialty drugmaker SciClone…

BTGChinaDC BeadHepatologyOncologyPharmaceuticalSciClone PharmaSciClone Pharmaceuticals

Prescribing habits for biosimilars will depend on robust clinical trials and manufacturer reputation

Prescribing habits for biosimilars will depend on robust clinical trials and manufacturer reputation

28-08-2014

Physicians across six different specialties expect that they will base prescribing decisions for biosimilars…

BiosimilarsBiotechnologyDecision Resources GroupMarkets & Marketing

UK NICE wants more info on type 2 diabetes drug Jardiance

UK NICE wants more info on type 2 diabetes drug Jardiance

28-08-2014

In a new draft guidance issued today, the UK drugs watchdog the National Institute for Health and Care…

Boehringer IngelheimDiabetesEli LillyJardiancePharmaceuticalPricingRegulationUK

Bristol-Myers’ hep C drug Daklinza approved in Europe

Bristol-Myers’ hep C drug Daklinza approved in Europe

27-08-2014

US pharma major Bristol-Myers Squibb says that the European Commission has approved Daklinza (daclatasvir),…

Anti-viralsBristol-Myers SquibbDaklinzaEuropeGilead SciencesPharmaceuticalRegulationSovaldi

FDA priority review for Amgen’s ivabradine in CHF

FDA priority review for Amgen’s ivabradine in CHF

27-08-2014

The US Food and Drug Administration has granted priority review designation for US biotech giant Amgen’s…

AmgenBiotechnologyCardio-vascularivabradineRegulationServierUSA

201 to 210 of 96134 results

Back to top